Emergent biosolution stock.

How much profit does Emergent BioSolutions generate each year? Emergent BioSolutions (NYSE:EBS) has a recorded net income of -$223.80 million. EBS has generated -$12.08 earnings per share over the last four quarters.

Emergent biosolution stock. Things To Know About Emergent biosolution stock.

Emergent became a publicly traded company in 2006, with its stock trading on the New York Stock Exchange under the symbol EBS. Mergers, acquisitions and joint ...Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use. February 15, 2023 17:19 ET ...Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Emergent BioSolutions stock is Reduce based on the current 1 sell rating and 1 hold rating for EBS. The average twelve-month price prediction for Emergent BioSolutions is $15.50 with a high price target of $22.00 and a low price target of $9.00. Sep 7, 2023 · Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Axsome Therapeutics (AXSM), a stock from the same industry, has gained 16.4%. Bavarian Nordic scoops up Emergent's travel vaccines, manufacturing site in deal worth up to $380M. After a tough third quarter in which Emergent BioSolutions cut more than $100 million from its ...

Emergent BioSolutions's revenue is forecast to decline at 7.4% per annum while its annual earnings are expected to grow at 77.9% per year. EPS is expected to grow by 79.8% per annum. Return on equity is forecast to be 19.7% in 3 years.22 thg 8, 2023 ... What happened. Shares of Emergent BioSolutions (EBS 11.68%) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P ...The stock price of government contractor Emergent BioSolutions has fallen sharply since the disclosure at the end of March that production problems at the firm’s plant in Baltimore had ruined 15 ...

Emergent Biosolutions stock has rallied 111% since late March (vs. about 53% for the S&P 500) to its current level around $105. The stock fell to a low of $50 in late March when a rapid increase ...Emergent Biosolutions Inc (EBS) stock is trading at $8.58 as of 11:21 AM on Monday, Mar 27, an increase of $0.48, or 5.93% from the previous closing price of $8.10. The stock has traded between $8.24 and $8.62 so far today. Volume today is light. So far 425,778 shares have traded compared to average volume of 1,546,652 shares.

Feb 28, 2023 · What happened. Emergent BioSolutions ( EBS 11.68%) probably wishes it had stayed in bed on Tuesday. The company's stock declined by nearly 12% that day, following its release of quarterly results ... 8 thg 11, 2023 ... Emergent BioSolutions Inc. (NYSE: EBS) reported Q3 2023 total revenues of $271M, a pre-tax loss of $(266)M, and adjusted EBITDA of $20M. The ...Nov 4, 2021 · Emergent BioSolutions ruined millions of doses of Covid-19 vaccines. Now its $600 million deal is canceled. Share full article. One of Emergent BioSolutions’ plants in Baltimore last April. View Emergent Biosolutions Inc EBS investment & stock information. Get the latest Emergent Biosolutions Inc EBS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Stock Quote & Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.

View Emergent Biosolutions Inc EBS investment & stock information. Get the latest Emergent Biosolutions Inc EBS detailed stock quotes, stock data, ...

Discover historical prices for EBS stock on Yahoo Finance. View daily, weekly or monthly format back to when Emergent BioSolutions Inc. stock was issued.The FDA approved Emergent BioSolutions Inc's (NYSE:EBS) anthrax vaccine for adults aged 18 through 65.. The vaccine Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, is ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Axsome Therapeutics (AXSM), a stock from the same industry, has gained 16.4%.Emergent BioSolutions Inc. shareholders can proceed in part with a lawsuit over sharp stock declines following news of contaminated Covid-19 vaccine batches at the company’s production facility and a canceled government contract, a federal court ruled. The investors plausibly alleged numerous intentional, material misrepresentations and ...MORE: In wake of Emergent BioSolutions' vaccine problems, CEO's stock trades come into focus The recent cross-contamination at the Baltimore plant is not the first time Emergent has had to answer ...

Dec 1, 2023 · How much profit does Emergent BioSolutions generate each year? Emergent BioSolutions (NYSE:EBS) has a recorded net income of -$223.80 million. EBS has generated -$12.08 earnings per share over the last four quarters. Emergent Biosolutions Inc. analyst ratings, historical stock prices, earnings estimates & actuals. EBS updated stock price target summary.Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 11.31% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $10.89. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as low as …146.71. +1.95%. 40.54M. View today's Emergent Biosolutions Inc stock price and latest EBS news and analysis. Create real-time notifications to follow any changes in the live stock price.Mar 29, 2023 · Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Exact Sciences (EXAS), a stock from the same industry, has gained 6.4%.

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 19.5% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $12.56 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.46 and as low as $7.74.Emergent BioSolutions has seen a significant revenue decline and stock value drop within the past year. The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses.

Benchmark upgraded Emergent BioSolutions Inc (NYSE:EBS) from Hold To Buy with a price target of $22 on the positive FDA and Narcan market news. Related: FDA Approves First OTC Naloxone Nasal Spray ...Shares of Emergent BioSolutions ( EBS) were soaring by 12.1% as of 10:34 a.m. ET on Thursday. The big gain came as concerns increased about a monkeypox outbreak in Europe. Monkeypox cases are also ...Stock Quote & Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.Nov. 4, 2021. WASHINGTON — The federal government has canceled its contract with a troubled Covid-19 vaccine manufacturer that ruined millions of doses and had to halt production for months ...Emergent Biosolutions Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Emergent Biosolutions Inc. Quarterly; Annual; Actual Analyst Range Consensus. 2.00 0.00-2.00. Actual-0.31 .Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, ... Kramer's previous significant sale of company stock under a SEC Rule 10b-5 plan was in April 2016, and several other Emergent executives also sold stock at that time.View the latest Emergent Biosolutions Inc. (EBS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Emergent BioSolutions reinstated with an Underweight at JPMorgan November 20, 2023TipRanks. Mixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and ...Emergent BioSolutions reinstated with an Underweight at JPMorgan November 20, 2023TipRanks. Mixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and ...

The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating. Price Target Upside/Downside. According to ...

Emergent BioSolutions. Market Cap. $108M. Today's Change. (%) Current Price. $2.09. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from ...

Emergent BioSolutions announced Thursday that the US Food and Drug Administration will allow it to resume the manufacturing of the drug substance that goes into Johnson & Johnson’s Covid-19 vaccine.Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing. GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock Exchange (NYSE) sent a notice that the company is not in compliance with Section …Why Emergent BioSolutions Stock Is Sinking Today (Motley Fool)-15.85%. Mar-10-23 06:56AM Emergent BioSolutions Inc. (NYSE:EBS) Q4 2022 Earnings Call Transcript (Insider Monkey) Mar-01-23 05:32AM Emergent BioSolutions Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall ...Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 19.59% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $13.67 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.33 and as low as $7.74.Apr 30, 2021 · For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. ... accused Emergent executives of inflating the company's stock price by ... May 10, 2022. WASHINGTON — Emergent BioSolutions, a longtime government contractor hired to produce hundreds of millions of coronavirus vaccine doses, hid evidence of quality control problems ...Emergent Biosolutions stock is currently +15.47% from its 52-week low of $1.81, and -87.46% from its 52-week high of $16.66. As of Nov 20, 2023, there are 51.81M EBS shares outstanding. The market value of EBS is $108.28M. In the past 24 hours, 844,197 EBS shares were traded.Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, ... Kramer's previous significant sale of company stock under a SEC Rule 10b-5 plan was in April 2016, and several other Emergent executives also sold stock at that time.

Shares of Emergent BioSolutions ( EBS 9.00%) were sliding 9.3% lower as of 11:13 a.m. EST on Friday. The decline came after Chardan Capital analyst Keay Nakae downgraded the stock from buy to hold ...Emergent BioSolutions Stock Price, News & Analysis (NYSE:EBS) $2.39 +0.25 (+11.68%) (As of 12/1/2023 08:54 PM ET) Compare Today's Range $2.01 $2.46 …Emergent BioSolutions ruined millions of doses of Covid-19 vaccines. Now its $600 million deal is canceled. Share full article. One of Emergent BioSolutions’ plants in Baltimore last April.Contract healthcare manufacturing company Emergent BioSolutions ( EBS -0.48%) was looking a bit under the weather as far as its stock was concerned on Tuesday. The company's share price plummeted ...Instagram:https://instagram. trade scanneryyy stock pricebrant floristapply for fha loan michigan Emergent BioSolutions Inc. (NYSE:NYSE:EBS) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ETCompany ParticipantsBob Burrows - VP, IRBob Kramer -...What happened. Shares of Emergent BioSolutions ( EBS -1.91%) are sinking today, down 11.8% as of 11:27 a.m. ET. The decline came after the company announced its second-quarter financial results ... futures broker usabest ira funds to invest in Emergent BioSolutions reinstated with an Underweight at JPMorgan November 20, 2023TipRanks. Mixed Financial Outlook for Emergent Biosolutions: Strong Narcan Sales Offset by Lowered Guidance and ... forex trading taxes May 10, 2023 · Emergent BioSolutions has seen a significant revenue decline and stock value drop within the past year. The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. Jan 9, 2023 · Revenue Metrics. Total revenues for 2022 are expected to be in the range of $1,100 million to $1,120 million, a decrease at the midpoint of $683 million or 38% as compared to 2021. Profitability ...